http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 13 Aug 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Press+Releases/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Globe+Newswire/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Globe+Newswire/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html <p align="justify">MONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=rJweYejt6g194suKGAXtbKnlKsd53XTNqy9dJo1axlQUgJK2aoWRBnN-QDEYEBG2rIMJAt8dGHIqpJnvp6HZtAljYNF642Oja0Le8_AJC4w=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=h5X3cqY4O9pwH7mlZCeBHunjt8nG46U9xCTro2JybC1pFLPbQz-lt92ZP9i4Fygw8QuTkKu6q4Q1IRCxaiiVXSaKS9lEU0ONOb1OmCtjllI=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=f_Iz9eUh8lNc3NEKebqXE2ynxphwXPOAPYPxBWGl4R3BMKvVcndczs6Ax1kiw0yzqOpWbtm4Yen1keUFuYYiL0GcaXAmNaHrhpQx_CTt_0LyXQSfdJVcL4Zzm6evDDdo" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=WwoXd_GDOq5D073c79WCvD_8PPbBOm3dVDtBhwLuSJMsdY-_D6O1JiSQMU2JUvM-TNwKCBnJ0lvuE2stjgUgkN2xgUkanzjIAyNlN8iQds_7Q-frGfLeW5u_2AijxxLT" rel="nofollow" target="_blank">FRA: 8CB0</a>),a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that the Toronto Stock Exchange (&quot;<strong>TSX</strong>&quot;) has accepted its notice of intention to proceed with a normal course issuer bid (&quot;<strong>NCIB</strong>&quot;).</p> <p align="justify">Pursuant to the NCIB, Cannara may purchase up to 1,975,642 of its common http://www.streetinsider.com/Globe+Newswire/Cannara+Announces+Normal+Course+Issuer+Bid/26798579.html Wed, 22 Jul 2026 08:00:00 -0400 8CB0 A.36078215 LOVE LOVFF O.02555813 O.41123081